By Sheeba M. | April 28, 2026
Schedule III Rescheduling Unleashes $Millions in Tax Savings for MSOs
Today marks a watershed moment for the cannabis industry. The DOJ Final Order issued April 23, 2026 officially moves state-licensed medical marijuana from Schedule I to Schedule III, and three related documents published on the Federal Register today confirm the shift is effective immediately.
What does this mean for investors? Money. Lots of it.
The Tax Advantage: Section 280E Relief
Under federal tax code Section 280E, cannabis businesses operating under state licenses could not deduct routine business expenses—rent, utilities, payroll, advertising. This created an effective tax rate of 60-70% for compliant operators, while black market competitors faced none of these burdens.
Schedule III rescheduling changes this. Multi-state operators (MSOs) like Curaleaf (CURA), Green Thumb Industries (GTBIF), and Trulieve (TRUL) will now be able to deduct ordinary business expenses, dramatically improving cash flow and profitability.
ATB Research estimates Tier 1 MSO EV/EBITDA multiples could expand from current 5.8x to 14.1x once full rescheduling impact is reflected in financial models. Translation: if an MSO earns $100M EBITDA today, that’s worth $580M. Post-rescheduling with full tax relief? That same $100M could be valued at $1.41B.
Who Wins First?
Vertically integrated operators with deep operations win hardest. Trulieve (TRUL) has already demonstrated operational excellence and is now sitting on potential 30-year tax refund claims. Curaleaf (CURA) is leading the sector recovery with improved supply chain efficiency, positioning them to capture margin expansion faster than competitors. Green Thumb (GTBIF) continues solidifying its footprint ahead of the consolidation wave.
The consolidation clock is now running. With rescheduling removing the “Schedule I stigma,” institutional capital is flowing in. MSOs with strong operations, deep capital, and clear tax strategies will be acquisition targets or acquirers—both routes create value for shareholders.
The Timeline
This week: DEA opens federal protections application process. Q2 2026: Tax savings begin flowing into MSO cash flows. Q3-Q4: Consolidation deals likely announced as valuation expansion creates M&A math that finally works.
Sources
- Foley & Lardner — Cannabis Rescheduling: DOJ, Treasury, and DEA Updates — Authoritative legal analysis of April 23-28 federal actions
- Marijuana Moment — DEA Protections Application Process Opens — Real-time regulatory tracking
- ATB Research — Valuation Analysis — Tier 1 MSO multiple expansion forecasts
Track cannabis stocks with the Weedstock Real-Time Tracker